663 research outputs found
The ALHAMBRA survey : band luminosity function of quiescent and star-forming galaxies at by PDF analysis
Our goal is to study the evolution of the band luminosity function (LF)
since using ALHAMBRA data. We used the photometric redshift and the
band selection magnitude probability distribution functions (PDFs) of those
ALHAMBRA galaxies with mag to compute the posterior LF. We
statistically studied quiescent and star-forming galaxies using the template
information encoded in the PDFs. The LF covariance matrix in
redshift-magnitude-galaxy type space was computed, including the cosmic
variance. That was estimated from the intrinsic dispersion of the LF
measurements in the 48 ALHAMBRA sub-fields. The uncertainty due to the
photometric redshift prior is also included in our analysis. We modelled the LF
with a redshift-dependent Schechter function affected by the same selection
effects than the data. The measured ALHAMBRA LF at and the
evolving Schechter parameters both for quiescent and star-forming galaxies
agree with previous results in the literature. The estimated redshift evolution
of is and , and of is
and . The measured faint-end slopes are and . We find a significant
population of faint quiescent galaxies, modelled by a second Schechter function
with slope . We find a factor decrease in the
luminosity density of star-forming galaxies, and a factor
increase in the of quiescent ones since , confirming the continuous
build-up of the quiescent population with cosmic time. The contribution of the
faint quiescent population to increases from 3% at to 6% at .
The developed methodology will be applied to future multi-filter surveys such
as J-PAS.Comment: Accepted for publication in Astronomy and Astrophysics. 25 pages, 20
figures, 7 table
f(R) theories
Over the past decade, f(R) theories have been extensively studied as one of
the simplest modifications to General Relativity. In this article we review
various applications of f(R) theories to cosmology and gravity - such as
inflation, dark energy, local gravity constraints, cosmological perturbations,
and spherically symmetric solutions in weak and strong gravitational
backgrounds. We present a number of ways to distinguish those theories from
General Relativity observationally and experimentally. We also discuss the
extension to other modified gravity theories such as Brans-Dicke theory and
Gauss-Bonnet gravity, and address models that can satisfy both cosmological and
local gravity constraints.Comment: 156 pages, 14 figures, Invited review article in Living Reviews in
Relativity, Published version, Comments are welcom
Researching the use of force: The background to the international project
This article provides the background to an international project on use of force by the police that was carried out in eight countries. Force is often considered to be the defining characteristic of policing and much research has been conducted on the determinants, prevalence and control of the use of force, particularly in the United States. However, little work has looked at police officers’ own views on the use of force, in particular the way in which they justify it. Using a hypothetical encounter developed for this project, researchers in each country conducted focus groups with police officers in which they were encouraged to talk about the use of force. The results show interesting similarities and differences across countries and demonstrate the value of using this kind of research focus and methodology
f(R,L_m) gravity
We generalize the type gravity models by assuming that the
gravitational Lagrangian is given by an arbitrary function of the Ricci scalar
and of the matter Lagrangian . We obtain the gravitational field
equations in the metric formalism, as well as the equations of motion for test
particles, which follow from the covariant divergence of the energy-momentum
tensor. The equations of motion for test particles can also be derived from a
variational principle in the particular case in which the Lagrangian density of
the matter is an arbitrary function of the energy-density of the matter only.
Generally, the motion is non-geodesic, and takes place in the presence of an
extra force orthogonal to the four-velocity. The Newtonian limit of the
equation of motion is also considered, and a procedure for obtaining the
energy-momentum tensor of the matter is presented. The gravitational field
equations and the equations of motion for a particular model in which the
action of the gravitational field has an exponential dependence on the standard
general relativistic Hilbert--Einstein Lagrange density are also derived.Comment: 6 pages, no figures; minor modifications, references added; accepted
for publication in EPJ
Green Criminology Before ‘Green Criminology’: Amnesia and Absences
Although the first published use of the term ‘green criminology’ seems to have been made by Lynch (Green criminology. Aldershot, Hampshire, 1990/2006), elements of the analysis and critique represented by the term were established well before this date. There is much criminological engagement with, and analysis of, environmental crime and harm that occurred prior to 1990 that deserves acknowledgement. In this article, we try to illuminate some of the antecedents of green criminology. Proceeding in this way allows us to learn from ‘absences’, i.e. knowledge that existed but has been forgotten. We conclude by referring to green criminology not as an exclusionary label or barrier but as a symbol that guides and inspires the direction of research
Cosmic acceleration and phantom crossing in -gravity
In this paper, we propose two new models in gravity to realize
universe acceleration and phantom crossing due to dark torsion in the
formalism. The model parameters are constrained and the observational test are
discussed. The best fit results favors an accelerating universe with possible
phantom crossing in the near past or future followed respectively by matter and
radiation dominated era.Comment: 20 pages, 18 figures, Will appear in Astrophys Space Sc
A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)
Meeting abstrac
Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049
- …